|
gptkbp:instanceOf
|
gptkb:drug
|
|
gptkbp:activeIngredient
|
gptkb:methylphenidate
|
|
gptkbp:approvalYear
|
2000
|
|
gptkbp:approvedBy
|
gptkb:FDA
|
|
gptkbp:ATCCode
|
N06BA04
|
|
gptkbp:brand
|
gptkb:methylphenidate_extended-release
|
|
gptkbp:contraindication
|
gptkb:glaucoma
anxiety
tics
hypersensitivity to methylphenidate
|
|
gptkbp:controlledSubstanceSchedule
|
gptkb:Schedule_II_(US)
|
|
gptkbp:eliminatedIn
|
urine
|
|
gptkbp:form
|
extended-release tablet
|
|
gptkbp:genericAvailable
|
yes
|
|
gptkbp:halfLife
|
3.5 hours
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
gptkb:Janssen_Pharmaceuticals
|
|
gptkbp:marketedIn
|
gptkb:Canada
gptkb:Europe
gptkb:United_States
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
headache
increased heart rate
insomnia
dry mouth
decreased appetite
|
|
gptkbp:usedFor
|
gptkb:attention_deficit_hyperactivity_disorder
narcolepsy
|
|
gptkbp:bfsParent
|
gptkb:Methylphenidate
gptkb:Ritalin
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Concerta
|